Fundz

Nanocan Therapeutics Corp reported raising $1.13 Million in an initial SEC Form D filing, from an offering of $1.4 Million

PRIVATEAug 27, 2020$1.1M of $1.4M raised

Amount Raised

$1.13 Million

$1.13 Million sold, per SEC Form D (first sale Aug 27, 2020)

Round Type

Seed

National HarborBiotechnologyHealthcare

Quick answer

Nanocan Therapeutics raised $1.13 Million in a Seed round, dated August 27, 2020. Nanocan Therapeutics is based in National Harbor, Maryland, United States.

How much did Nanocan Therapeutics raise?
Nanocan Therapeutics raised $1.13 Million in a Seed round on August 27, 2020.
What does Nanocan Therapeutics do?
Nanocan Therapeutics Corporation is an early-stage biotechnology company developing novel drug-delivery nanotechnology for more precise and targeted treatment of cancer and respiratory diseases.
Where is Nanocan Therapeutics based and how big is it?
Nanocan Therapeutics is based in National Harbor, Maryland, United States.
Who are the decision-makers at Nanocan Therapeutics?
Fundz holds 1 contact at Nanocan Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Nanocan Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Singletto raised $75K on October 6, 2020.
  • Vigil Neuroscience raised $30M on October 5, 2020.
  • OnKure Therapeutics raised $1.5M (Seed) on September 30, 2020.
  • Ingenia Therapeutics raised $4.7M (Seed) on September 29, 2020.
  • INCOG BioPharma Services raised $29M on September 29, 2020.
  • E-scape Bio, Inc. raised $73M on September 28, 2020.

Who to call at Nanocan Therapeutics, and when

A new round usually means Nanocan Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nanocan Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nanocan Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nanocan Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nanocan Therapeutics

Location

137 NATIONAL PLZ STE 300

National Harbor, Maryland, United States

About

Nanocan Therapeutics Corporation is an early-stage biotechnology company developing novel drug-delivery nanotechnology for more precise and targeted treatment of cancer and respiratory diseases. More precise local treatment can unlock local immune-driven potential and significantly reduce the risk of side effects. Through our partnerships with leading academic research institutions, we are rapidly developing new shorter and efficient combination therapies to help improve the lives of patients and improve global access to care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nanocan Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts2 people are listed at Nanocan Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Nanocan Therapeutics's next move

See what Strategic adds

Nanocan Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.